Invention Grant
![Oxaspiro[2.5]octane derivatives and analogs](/docs/US/2016-05-03/US09328082B2/abs.jpg.600x600.jpg)
- Patent Title: Oxaspiro[2.5]octane derivatives and analogs
- Patent Title (中): Oxaspiro [2.5]辛烷衍生物和类似物
-
Application No.: US14003906Application Date: 2012-03-07
-
Publication No.: US09328082B2Publication Date: 2016-05-03
- Inventor: James E. Vath , Stuart Chaffee
- Applicant: James E. Vath , Stuart Chaffee
- Applicant Address: US MA Boston
- Assignee: Zafgen, Inc.
- Current Assignee: Zafgen, Inc.
- Current Assignee Address: US MA Boston
- Agency: Goodwin Procter LLP
- International Application: PCT/US2012/028068 WO 20120307
- International Announcement: WO2012/122264 WO 20120913
- Main IPC: C07D303/22
- IPC: C07D303/22 ; A61K31/336 ; C07D303/32 ; C07D303/34 ; C07D303/36 ; C07D405/14 ; C07D453/02 ; C07D491/10 ; C07D493/10
![Oxaspiro[2.5]octane derivatives and analogs](/abs-image/US/2016/05/03/US09328082B2/abs.jpg.150x150.jpg)
Abstract:
The invention provides oxaspiro[2.5]octane derivatives and analogs, methods for preparation thereof, intermediates thereto, pharmaceutical compositions, and uses thereof in the treatment of various disorders and conditions, such as overweight and obesity.
Public/Granted literature
- US20150045427A1 Oxaspiro[2.5]Octane Derivatives and Analogs Public/Granted day:2015-02-12
Information query
